COO Stock - The Cooper Companies, Inc.
Unlock GoAI Insights for COO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $4.09B | $3.90B | $3.59B | $3.31B | $2.92B |
| Gross Profit | $2.48B | $2.60B | $2.36B | $2.14B | $1.96B |
| Gross Margin | 60.7% | 66.6% | 65.6% | 64.7% | 66.9% |
| Operating Income | $682.90M | $705.70M | $533.10M | $507.60M | $505.80M |
| Net Income | $374.90M | $392.30M | $294.20M | $385.80M | $2.94B |
| Net Margin | 9.2% | 10.1% | 8.2% | 11.7% | 100.8% |
| EPS | $1.87 | $1.97 | $1.49 | $1.96 | $59.73 |
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Visit WebsiteEarnings History & Surprises
COOEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 27, 2026 | — | — | — | — |
Q1 2026 | Mar 5, 2026 | $1.03 | — | — | — |
Q4 2025 | Dec 4, 2025 | $1.11 | $1.15 | +3.6% | ✓ BEAT |
Q3 2025 | Aug 27, 2025 | $1.07 | $1.10 | +2.8% | ✓ BEAT |
Q2 2025 | May 29, 2025 | $0.93 | $0.96 | +3.4% | ✓ BEAT |
Q1 2025 | Mar 6, 2025 | $0.91 | $0.92 | +0.7% | ✓ BEAT |
Q4 2024 | Dec 5, 2024 | $1.00 | $1.04 | +4.0% | ✓ BEAT |
Q3 2024 | Aug 28, 2024 | $0.91 | $0.96 | +5.4% | ✓ BEAT |
Q2 2024 | May 30, 2024 | $0.83 | $0.85 | +2.5% | ✓ BEAT |
Q1 2024 | Feb 29, 2024 | $0.78 | $0.85 | +8.6% | ✓ BEAT |
Q4 2023 | Dec 7, 2023 | $0.87 | $0.87 | 0.0% | = MET |
Q3 2023 | Aug 30, 2023 | $0.84 | $0.84 | 0.0% | = MET |
Q2 2023 | Jun 1, 2023 | $0.75 | $0.77 | +2.7% | ✓ BEAT |
Q1 2023 | Mar 2, 2023 | $0.67 | $0.73 | +9.0% | ✓ BEAT |
Q4 2022 | Dec 8, 2022 | $0.77 | $0.69 | -10.4% | ✗ MISS |
Q3 2022 | Aug 31, 2022 | $0.80 | $0.80 | 0.0% | = MET |
Q2 2022 | Jun 2, 2022 | $0.85 | $0.81 | -4.7% | ✗ MISS |
Q1 2022 | Mar 3, 2022 | $0.77 | $0.81 | +5.2% | ✓ BEAT |
Q4 2021 | Dec 2, 2021 | $0.84 | $0.82 | -2.4% | ✗ MISS |
Q3 2021 | Sep 2, 2021 | $0.83 | $0.85 | +2.4% | ✓ BEAT |
Latest News
Frequently Asked Questions about COO
What is COO's current stock price?
What is the analyst price target for COO?
What sector is The Cooper Companies, Inc. in?
What is COO's market cap?
Does COO pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to COO for comparison